Benzinga | Nov 2, 2021 10:53AM EDT

Oppenheimer Maintains Outperform on Akoustis Technologies, Lowers Price Target to $13

Oppenheimer analyst Rick Schafer maintains Akoustis Technologies (NASDAQ:AKTS) with a Outperform and lowers the price target from $18 to $13.